ArticleNature communications2021
Near-ideal van der Waals rectifiers based on all-two-dimensional Schottky junctions.
Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 219 citations in OpenAlex.
- Re-Thinking Electronic Circuit Design Through Emerging Reconfigurable Field Effect Transistors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Reconfigurable Optoelectronic Logic Gates Enabled by a VSeNanomaterials (Basel, Switzerland) · 2026Article
- Two-dimensional digital-analog multimode circuits based on asymmetric vertical double-gate WSeNature communications · 2026Article
- Gate-level three-dimensional integration of two-dimensional logic cells.Nature communications · 2026Article
- High-Performance KVSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- On-Chip Direct Synthesis of 2D Semimetals for van der Waals Metal-Semiconductor Junction Transistor Arrays.ACS nano · 2026Article
- Emerging Device Applications From Strong Light-Matter Interactions in 2D Materials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Low bias negative differential resistance in WSeScientific reports · 2025Article
- Direct Formation of Stable 1T' Molybdenum Telluride (MoTeACS applied materials & interfaces · 2025Article
- Bilateral Geiger mode avalanche in InSe Schottky photodiodes.Nature communications · 2025Article
- Interface Effects in Metal-2D TMDs Systems: Advancing the Design and Development Electrocatalysts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Ultranarrow Semiconductor WSNano letters · 2025Article
- Layer-dependent Schottky contact at TaXNanoscale advances · 2025Article
- Designing 2D carbon dot nanoreactors for alcohol oxidation coupled with hydrogen evolution.Nature communications · 2024Article
- The Contact Properties of Monolayer and Multilayer MoSNanomaterials (Basel, Switzerland) · 2024Article
- Asymmetric Schottky Barrier-Generated MoSNanomaterials (Basel, Switzerland) · 2024Article
- Fabrication of p-type 2D single-crystalline transistor arrays with Fermi-level-tuned van der Waals semimetal electrodes.Nature communications · 2023Article
- Contact-engineered reconfigurable two-dimensional Schottky junction field-effect transistor with low leakage currents.Nature communications · 2023Article
- Highly Sensitive MoSACS applied materials & interfaces · 2023Article
- Deterministic Light-to-Voltage Conversion with a Tunable Two-Dimensional Diode.ACS photonics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 3 institutions in 1 country.
Funding
Abstract
The applications of any two-dimensional (2D) semiconductor devices cannot bypass the control of metal-semiconductor interfaces, which can be severely affected by complex Fermi pinning effects and defect states. Here, we report a near-ideal rectifier in the all-2D Schottky junctions composed of the 2D metal 1 T'-MoTe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.